{"id":6849,"date":"2026-06-25T15:16:00","date_gmt":"2026-06-25T08:16:00","guid":{"rendered":"https:\/\/productregistrationindonesia.com\/"},"modified":"2026-06-25T15:16:01","modified_gmt":"2026-06-25T08:16:01","slug":"bpom-food-supplement-registration-guide","status":"publish","type":"post","link":"https:\/\/productregistrationindonesia.com\/ja\/bpom-food-supplement-registration-guide\/","title":{"rendered":"Two Walls Every Supplement Brand Hits with BPOM, and Importantly, How to Get Through Them"},"content":{"rendered":"

Navigating Indonesia’s food supplement registration when your product is contract-manufactured abroad or contains an ingredient BPOM hasn’t seen before.<\/p>\n\n\n\n

Contract Manufacturing, and the Problem BPOM Creates for Importers<\/h2>\n\n\n\n

Contract manufacturing (known locally as maklon<\/em>, or globally as OEM) is the backbone of the supplement industry. A brand owner designs the formula, a third-party factory produces it, and the brand owner sells it under their own name. Straightforward. Except for BPOM. They don’t see it that way.<\/p>\n\n\n\n

BPOM does have a box for OEM imports, but it is locked behind impossible protectionist requirements (proving local factories can’t make it). Therefore, the only viable strategy for foreign brand owners is to legally masquerade their OEM factory as a “Foreign Principal” via the Standard Import pathway, using a CFS and an LoA.<\/p>\n\n\n\n

BPOM does formally recognize contract manufacturing, officially defining it as Suplemen Kesehatan Kontrak (Contract Health Supplements). When an Indonesian entity uses a foreign OEM, it falls under a highly specific registration pathway called Contract Manufacturing Abroad (Kontrak ke Luar Negeri).<\/p>\n\n\n\n

\u26a0\u00a0 THE CORE PROBLEM<\/strong>
BPOM intentionally makes the “Contract Manufacturing Abroad” pathway nearly impossible for standard brand owners to use. To register a product through this specific OEM box, BPOM requires two strict conditions that most importers fail:The Registrant Restriction: A standard Indonesian trading company or distributor (PT) cannot apply for this. The Indonesian registrant must be a licensed Pharmaceutical Industry (Industri Farmasi) or a Traditional Medicine Industry (IOT).The Technology Barrier: You must formally prove with justification documents that the technology and facilities required to manufacture your supplement do not yet exist in Indonesia.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

In practice, the registrant (an Indonesian legal entity) must present a valid manufacturing certificate and Letter of Authorization (LoA) from the overseas factory. Without recognising OEM as a relationship type, BPOM interprets the factory as a passive supplier, raising questions about who is actually accountable for product quality. This is the friction point most importers hit.<\/p>\n\n\n\n

Because most brand owners cannot prove a “lack of local technology,” they are forced to abandon the “Contract Manufacturing” pathway and squeeze their OEM arrangement into the Standard Import (Suplemen Kesehatan<\/a> Impor) pathway, which triggers the aforementioned friction points.<\/p>\n\n\n\n

\u201cBPOM simply doesn\u2019t have a box to put OEM products in. Your job is to fit the arrangement into a box it already recognises\u201d<\/em><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

POSSIBLE WAY OUTS<\/strong><\/p>\n\n\n\n

A<\/td>Letter of Authorization + Manufacturing Agreement (most common)<\/strong>The overseas manufacturer issues a formal LoA authorising a named Indonesian entity to register and commercialise the product in Indonesia. Pair this with a manufacturing agreement and a Certificate of Free Sale (CFS) from the country of origin. This is the cleanest path for most OEM arrangements; BPOM receives it as a brand-licensing relationship rather than a pure OEM play.<\/td><\/tr>
B<\/td>Register under a licensed local distributor or principal<\/strong>While partnering with a local distributor is the right move, BPOM will not treat your OEM factory as “their contracted manufacturer.” Because the local distributor is not in the pharmaceutical industry, they are legally barred from using the contract manufacturing route. BPOM will evaluate this exactly like Option A: a standard import where the foreign OEM is recognized as the Principal supplying a local distributor.<\/td><\/tr>
C<\/td>Negotiate brand co-ownership with the factory<\/strong>In some cases, the OEM factory agrees to be listed as the brand owner (or co-owner) for the Indonesian registration specifically, while commercial rights remain with you via a separate private agreement. This works when the factory relationship is strong and long-term, but it creates a legal dependency that must be structured carefully. 
This is the most practical workaround for the “CFS Catch-22.” Because BPOM requires a CFS for standard imports, the product must actually be legally registered and free to be sold in the OEM’s home country. Many OEMs manufacture exclusively for export and cannot get a CFS. Having the factory co-own or register the brand locally in their country to secure the government-issued CFS is a mandatory step before they can issue the LoA to your Indonesian distributor<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
\ud83d\udca1\u00a0 PRACTICAL NOTE<\/strong>
Whichever route you choose, ensure your overseas factory holds GMP certification recognised by BPOM (ISO 22000, HACCP, or a national GMP certificate). Without it, no amount of legal structuring will get the registration through. BPOM\u2019s Directorate for Food Processed Products handles supplement imports, getting their pre-submission guidance informally can save months.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n\n\n\n

When an Ingredient Isn\u2019t on BPOM\u2019s Approved List<\/h2>\n\n\n\n

BPOM maintains a positive list of permitted ingredients for food supplements under its regulations (Peraturan BPOM tentang Bahan Tambahan Pangan<\/a> and related decrees). If your formula contains an ingredient outside this list, a novel botanical, a proprietary peptide, a cutting-edge micronutrient, the registration will stall or be outright rejected.<\/p>\n\n\n\n

The instinct is to ask first. That instinct is correct. The question is how you ask.<\/p>\n\n\n\n

\n
Navigating BPOM Registration for New Supplement Ingredients in Indonesia<\/a><\/blockquote>